NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	31/05/2017
Target sample size	297
Countries of recruitment	Japan,Asia except Japan,North America,South America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : SB240563(Mepolizumab) Therapeutic category code : 229 Other agents affecting respiratory organs Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	other
Secondary Outcome	other

Key inclusion & exclusion criteria

Age minimum	>= 6age old
Age maximum	<= 11age old
Gender	Both
Include criteria
Exclude criteria